These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8369004)

  • 1. Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application.
    Woodcock BG; Merz PG; Rietbrock S; Rudolph B; Pfleiderer S
    Arzneimittelforschung; 1993 Jul; 43(7):734-6. PubMed ID: 8369004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steady-state kinetics of a fatty-alcohol based slow release nifedipine formulation in 60 mg, 90 mg and 120 mg dosages daily.
    Merz PG; Rietbrock S; Pfleiderer S; Woodcock BG
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):480-1. PubMed ID: 1490792
    [No Abstract]   [Full Text] [Related]  

  • 3. [The bioequivalence of two nifedipine sustained-release formulations after single administration in steady state].
    Meyer FP; Banditt P
    Arzneimittelforschung; 1993 Jun; 43(6):646-50. PubMed ID: 8352817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioavailability of three different galenic nifedipine preparations.
    Pabst G; Lutz D; Molz KH; Dahmen W; Jaeger H
    Arzneimittelforschung; 1986 Feb; 36(2):256-60. PubMed ID: 3964332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug input rate from the GI-tract. Michaelis-Menten kinetics and the bioavailability of slow release verapamil and nifedipine.
    Woodcock BG; Menke G; Fischer A; Köhne H; Rietbrock N
    Drug Des Deliv; 1988 May; 2(4):299-310. PubMed ID: 3255321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bioequivalence of nifedipine sustained-release formulations in comparison to standard preparations in solid state].
    Herrmann R
    Arzneimittelforschung; 1996 Jan; 46(1):28-34. PubMed ID: 8821514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
    Darwish M; Chang S; Hellriegel ET
    Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nifedipine pharmacokinetics and plasma levels in the management of preterm labor.
    Papatsonis DN; Bos JM; van Geijn HP; Lok CA; Dekker GA
    Am J Ther; 2007; 14(4):346-50. PubMed ID: 17667209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
    Reiz JL; Donnelly GA; Michalko K
    Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of an oral once-a-day controlled-release oxybutynin formulation compared with immediate-release oxybutynin.
    Gupta SK; Sathyan G
    J Clin Pharmacol; 1999 Mar; 39(3):289-96. PubMed ID: 10073329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence and relative bioavailability of a new diltiazem sustained release formulation.
    Scheiwe MW; Lankhaar G; Kleinbloesem CH
    Arzneimittelforschung; 1996 Oct; 46(10):960-3. PubMed ID: 8931888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxel.
    Britten CD; Baker SD; Denis LJ; Johnson T; Drengler R; Siu LL; Duchin K; Kuhn J; Rowinsky EK
    Clin Cancer Res; 2000 Sep; 6(9):3459-68. PubMed ID: 10999729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.